Jacobio Pharmaceuticals (01167) Announces Monthly Securities Return for January 2026

Bulletin Express
Feb 05

Jacobio Pharmaceuticals Group Co., Ltd. (01167) submitted a Monthly Return for the period ended 31 January 2026. The authorized share capital remained at 1,000,000,000 ordinary shares with a par value of USD 0.0001 each, totaling USD 100,000 and showing no change within the month.

The number of issued shares (excluding treasury shares) at the end of January was 786,672,780, while treasury shares increased to 5,082,300. The total number of issued shares stayed at 791,755,080. These changes resulted from two share repurchases: 150,000 shares on 2 January 2026 at HKD 6.44 each and 240,000 shares on 6 January 2026 at HKD 6.19 each.

According to the filing, the company maintained compliance with the applicable public float requirement of 25%. The announcement was filed by Director Xiaojie Wang on 5 February 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10